![]() | Up a level |
Lawrence, David S, Youssouf, Nabila, Molloy, Sile LF, Alanio, Alexandre, Alufandika, Melanie, Boulware, David R, Boyer-Chammard, Timothee, Chen, Tao ORCID: 0000-0002-5489-6450, Dromer, Francoise, Hlupeni, Admire et al (show 19 more authors)
(2018)
AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.
TRIALS, 19 (1).
649-.
Lawrence, David S, Youssouf, Nabila, Molloy, Sile F, Alanio, Alexandre, Alufandika, Melanie, Boulware, David R, Boyer-Chammard, Timothee, Chen, Tao ORCID: 0000-0002-5489-6450, Dromer, Francoise, Hlupeni, Admire et al (show 19 more authors)
(2019)
AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial (vol 19, 649, 2018).
TRIALS, 20 (1).
48-.
Ponatshego, Ponego Lloyd, Lawrence, David Stephen, Youssouf, Nabila, Molloy, Sile F, Alufandika, Melanie, Bango, Funeka, Boulware, David R, Chawinga, Chimwemwe, Dziwani, Eltas, Gondwe, Ebbie et al (show 28 more authors)
(2019)
AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: economic evaluation protocol for a randomised controlled trial-based equivalence study.
BMJ OPEN, 9 (4).
e026288-.
Lawrence, David S, Tsholo, Katlego, Ssali, Agnes, Mupambireyi, Zivai, Hoddinott, Graeme, Nyirenda, Deborah ORCID: 0000-0002-5867-4687, Meya, David B, Ndhlovu, Chiratidzo, Harrison, Thomas S, Jarvis, Joseph N et al (show 1 more authors)
(2021)
The Lived Experience Of Participants in an African RandomiseD trial (LEOPARD): protocol for an in-depth qualitative study within a multisite randomised controlled trial for HIV-associated cryptococcal meningitis.
BMJ OPEN, 11 (4).
e039191-.
Stott, Katharine E ORCID: 0000-0001-7079-7957, Moyo, Melanie, Ahmadu, Ajisa, Kajanga, Cheusisime, Gondwe, Ebbie, Chimang'anga, Wezzie, Chasweka, Madalitso, Leeme, Tshepo B, Molefi, Mooketsi, Chofle, Awilly et al (show 11 more authors)
(2022)
Population pharmacokinetics of liposomal amphotericin B in adults with HIV-associated cryptococcal meningoencephalitis.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 78 (1).
pp. 276-283.
Jarvis, Joseph N, Leeme, Tshepo B, Molefi, Mooketsi, Chofle, Awilly A, Bidwell, Gabriella, Tsholo, Katlego, Tlhako, Nametso, Mawoko, Norah, Patel, Raju KK, Tenforde, Mark W et al (show 9 more authors)
(2019)
Short-course High-dose Liposomal Amphotericin B for Human Immunodeficiency Virus-associated Cryptococcal Meningitis: A Phase 2 Randomized Controlled Trial.
CLINICAL INFECTIOUS DISEASES, 68 (3).
pp. 393-401.
Jarvis, Joseph N ORCID: 0000-0003-1459-5554, Lawrence, David S
ORCID: 0000-0002-5439-4039, Meya, David B, Kagimu, Enock, Kasibante, John, Mpoza, Edward, Rutakingirwa, Morris K, Ssebambulidde, Kenneth
ORCID: 0000-0002-8125-0698, Tugume, Lillian, Rhein, Joshua
ORCID: 0000-0002-0480-9646 et al (show 33 more authors)
(2022)
Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis.
The New England journal of medicine, 386 (12).
pp. 1109-1120.